Table 1.
Latency and duration of suppression of motor activity by CRF, non-NMDA agonists, NMDA agonists, and NMDA antagonists microinjected into the NMC
| Chemicals | n | Latency (s) | Duration (min) |
|---|---|---|---|
|
| |||
| CRF (10 nM) | 6 | 29±12.1 | 3.8±1.42 |
| Kainate (0.2 mM) | 12 | 38±20.7 a | 4.7±1.06 |
| Quisqualate (10 mM) | 15 | 36±21.5 a | 4.3±0.87 |
| NMDA (6.8 mM) | 8 | 31±10.4 | 3.4±0.46 |
| APV (50 mM) | 11 | 46±22.6 b | 624±48.6 |
| AP5 (20 mM) | 5 | 36±25.8 b | 586±53.8 |
a
Results from injections at the border of NMC and NGC are not included.
b
Results from injections at the border of NMC and NPM are not included.